ITMI20000630A0 - Impiego del resveratrolo per il trattamento di eczema disquamativo anche e psoriasi - Google Patents

Impiego del resveratrolo per il trattamento di eczema disquamativo anche e psoriasi

Info

Publication number
ITMI20000630A0
ITMI20000630A0 IT2000MI000630A ITMI20000630A ITMI20000630A0 IT MI20000630 A0 ITMI20000630 A0 IT MI20000630A0 IT 2000MI000630 A IT2000MI000630 A IT 2000MI000630A IT MI20000630 A ITMI20000630 A IT MI20000630A IT MI20000630 A0 ITMI20000630 A0 IT MI20000630A0
Authority
IT
Italy
Prior art keywords
disquamative
resveratrol
eczema
psoriasis
treatment
Prior art date
Application number
IT2000MI000630A
Other languages
English (en)
Inventor
Maria Teresa Pelliccia
Attilio Giannella
Jenny Giannella
Original Assignee
Nuova Ict S R L
D B P Dev Biotechnologica L Pr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nuova Ict S R L, D B P Dev Biotechnologica L Pr filed Critical Nuova Ict S R L
Priority to IT2000MI000630A priority Critical patent/IT1318425B1/it
Publication of ITMI20000630A0 publication Critical patent/ITMI20000630A0/it
Priority to EP01106638A priority patent/EP1138323A3/en
Priority to US09/813,948 priority patent/US20010056071A1/en
Publication of ITMI20000630A1 publication Critical patent/ITMI20000630A1/it
Application granted granted Critical
Publication of IT1318425B1 publication Critical patent/IT1318425B1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IT2000MI000630A 2000-03-24 2000-03-24 Impiego del resveratrolo per il trattamento di eczema desquamativo,acne e psoriasi. IT1318425B1 (it)

Priority Applications (3)

Application Number Priority Date Filing Date Title
IT2000MI000630A IT1318425B1 (it) 2000-03-24 2000-03-24 Impiego del resveratrolo per il trattamento di eczema desquamativo,acne e psoriasi.
EP01106638A EP1138323A3 (en) 2000-03-24 2001-03-16 Resveratrol for the treatment of exfoliative eczema, acne or psoriasis
US09/813,948 US20010056071A1 (en) 2000-03-24 2001-03-22 Use of resveratrol for the treatment of exfoliative eczema, acne and psoriasis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2000MI000630A IT1318425B1 (it) 2000-03-24 2000-03-24 Impiego del resveratrolo per il trattamento di eczema desquamativo,acne e psoriasi.

Publications (3)

Publication Number Publication Date
ITMI20000630A0 true ITMI20000630A0 (it) 2000-03-24
ITMI20000630A1 ITMI20000630A1 (it) 2001-09-24
IT1318425B1 IT1318425B1 (it) 2003-08-25

Family

ID=11444631

Family Applications (1)

Application Number Title Priority Date Filing Date
IT2000MI000630A IT1318425B1 (it) 2000-03-24 2000-03-24 Impiego del resveratrolo per il trattamento di eczema desquamativo,acne e psoriasi.

Country Status (3)

Country Link
US (1) US20010056071A1 (it)
EP (1) EP1138323A3 (it)
IT (1) IT1318425B1 (it)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6878751B1 (en) * 2000-10-19 2005-04-12 Imperial College Of Science Technology And Medicine Administration of resveratrol to treat inflammatory respiratory disorders
US7977049B2 (en) 2002-08-09 2011-07-12 President And Fellows Of Harvard College Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms
US6866856B2 (en) * 2002-12-31 2005-03-15 Avon Products, Inc. Compositions and delivery methods for the treatment of wrinkles, fine lines and hyperhidrosis
JP2007530417A (ja) 2003-07-01 2007-11-01 プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ 細胞及び生物の寿命及びストレス応答を操作するための組成物
US7758903B2 (en) 2003-09-12 2010-07-20 Access Business Group International Llc Cytokine modulators and related methods of use
CN102309573B (zh) * 2003-09-12 2013-11-20 捷通国际有限公司 细胞因子调节剂及相关用法
US7758902B2 (en) * 2003-09-12 2010-07-20 Access Business Group International Llc Cytokine modulators and related methods of use
JP2007527418A (ja) 2003-12-29 2007-09-27 プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ 肥満及びインシュリン耐性障害を治療又は防止するための組成物
US8017634B2 (en) 2003-12-29 2011-09-13 President And Fellows Of Harvard College Compositions for treating obesity and insulin resistance disorders
US8404667B2 (en) * 2006-12-29 2013-03-26 Wisconsin Alumni Research Foundation Compounds, compositions, kits and methods of use to orally and topically treat acne and other skin conditions by 19-Nor vitamin D analog
DE602004026647D1 (de) * 2004-09-14 2010-05-27 Ajinomoto Omnichem S A Topische zusammensetzungen mit phosphorylierten polyphenolen
US7740875B2 (en) 2004-10-08 2010-06-22 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
US20060078580A1 (en) 2004-10-08 2006-04-13 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
PL207034B1 (pl) * 2004-12-30 2010-10-29 Inst Farmaceutyczny Sposób wytwarzania bezwodnego kalcypotriolu
DE102005005274A1 (de) * 2005-02-04 2006-08-10 Peter Heger Verwendung von Hydroxystilben-haltigen Wirkstoffen zur Prävention und Behandlung chronisch-entzündlicher Erkrankungen
FR2882502B1 (fr) * 2005-02-25 2007-04-20 Claude Bonne Complements alimentaires destines aux patients atteints de psoriasis
EP1726292A1 (en) * 2005-05-23 2006-11-29 Reckitt Benckiser (UK) LIMITED Composition comprising resveratrol and topical use thereof for reducing human hair growth
WO2006138418A2 (en) 2005-06-14 2006-12-28 President And Fellows Of Harvard College Improvement of cognitive performance with sirtuin activators
KR100795513B1 (ko) 2006-06-16 2008-01-16 바이오스펙트럼 주식회사 피노실빈과 로즈마린산을 포함하는 항염 조성물
ES2689715T3 (es) * 2007-05-14 2018-11-15 Sytheon Ltd. Composiciones para tratamiento de la piel y métodos
US20090137534A1 (en) * 2007-11-26 2009-05-28 Chaudhuri Ratan K Skin treatment compositions and methods
US9616006B2 (en) * 2007-10-10 2017-04-11 DermaMedics, LLC Methods and compositions for treating dermatological diseases and conditions
EP2082736A1 (fr) * 2008-01-23 2009-07-29 Jean Hilaire Saurat Composition pharmaceutique à usage topique
CA2629979A1 (en) * 2008-04-25 2009-10-25 Pharmascience Inc. Novel resveratrol compositions
US20100124576A1 (en) * 2008-11-14 2010-05-20 Teri Amato Topical Treatment Formulation of Natural Ingredients for Enhancing Sexual Response
US9050284B2 (en) * 2009-02-09 2015-06-09 Sami Labs Limited Orally bioavailable stilbenoids—compositions and therapeutic applications thereof
WO2011039175A1 (en) * 2009-09-29 2011-04-07 Bodo Melnik Treatment of acne vulgaris, rosacea and androgenetic alopecia and cancer protection in smokers, obesity and diabetes mellitus
CA2792035A1 (en) * 2010-03-02 2011-09-09 Vindico Nanobio Technology, Inc. Compositions and methods for treating or preventing immuno-inflammatory disease
JP2018510905A (ja) * 2015-02-16 2018-04-19 エグザンシャル 皮膚障害の予防又は治療のための組成物
JP2019514983A (ja) * 2016-05-03 2019-06-06 スキアダーム， インコーポレイテッド エネルギー代謝を標的とする薬剤での活性化真皮状態の処置
WO2020187803A1 (en) * 2019-03-20 2020-09-24 Rita Dobmeyer Pharmaceutical composition

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3053368B2 (ja) * 1996-06-06 2000-06-19 ユシロ化学工業株式会社 化粧料及びその製造方法
US5935596A (en) * 1997-03-20 1999-08-10 Chesebrough-Pond's Usa Co. Delivery of skin benefit agents via adhesive strips
US6270780B1 (en) * 1997-07-25 2001-08-07 Chesebrough-Pond's Usa Co., Division Of Conopco Cosmetic compositions containing resveratrol
BR9803596A (pt) * 1997-09-23 2000-04-25 Pfizer Prod Inc Derivados do resorcinol.
US6414037B1 (en) * 1998-01-09 2002-07-02 Pharmascience Pharmaceutical formulations of resveratrol and methods of use thereof
FR2777184B1 (fr) * 1998-04-10 2001-08-24 Oreal Utilisation d'au moins un hydroxystilbene en tant qu'agent diminuant l'adhesion des micro-organismes
WO1999059561A2 (en) * 1998-05-18 1999-11-25 Hensley, Kenneth, L. Resveratrol inhibition of myeloperoxidase
CA2350396C (en) * 1998-12-24 2010-06-29 1333366 Ontario Inc. A composition useful to treat periodontal disease
US6358517B1 (en) * 1999-10-22 2002-03-19 Unilever Home & Personal Care Usa, Division Of Conopco Cosmetic compositions containing resveratrol and retinoids
WO2001043705A2 (en) * 1999-12-16 2001-06-21 Johnson & Johnson Consumer Companies, Inc. Compositions containing a retinoid and a stilbene for skin care

Also Published As

Publication number Publication date
US20010056071A1 (en) 2001-12-27
EP1138323A3 (en) 2001-10-24
ITMI20000630A1 (it) 2001-09-24
IT1318425B1 (it) 2003-08-25
EP1138323A2 (en) 2001-10-04

Similar Documents

Publication Publication Date Title
ITMI20000630A0 (it) Impiego del resveratrolo per il trattamento di eczema disquamativo anche e psoriasi
EE05507B1 (et) Rosuvastatiini ZD4522) kasutamine heterosgootseperekondliku hperkolesteroleemia raviks
EE200200461A (et) Pteridiiniühendid psoriaasi raviks
AR028296A1 (es) Metodos sinergisticos y composiciones para el tratamiento del cancer
HK1068551A1 (en) Substituted benzimidazole compounds and their use for the treatment of cancer
IT1318649B1 (it) Composizioni farmaceutiche per il trattamento di mucositi e stomatiti.
DK2455083T3 (da) Farmaceutisk sammensætning til dermal anvendelse omfattende calcipotriol og betamethason til behandling af psoriasis
EE05481B1 (et) Kinasoliini derivaadid kasvajate raviks
DK1248608T3 (da) Diacerein til anvendelse i behandling af psoriasis
IS6966A (is) Cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma
IS6967A (is) Ný cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma
DE60129829D1 (de) Zyklisierte benzamid-neurokinin-antagonisten zur verwendung in therapie
NO20026219L (no) Forbindelser for behandling av svekket fundisk relaksasjon
NO20024236L (no) Behandling av psoriasis
EE200400074A (et) Koostised ning nende kasutamine proliferatiivsetehaiguste raviks
DE60222664D1 (de) Hautbehandlungsmittel
EE200200479A (et) Eksemestaani kasutamine rinnavähi ravis
NO20023803D0 (no) Anvendelse av mirtazapin for behandling av sövnforstyrrelser
EE200300057A (et) Koostis vähi profülaktikaks ja raviks
IT1320192B1 (it) Composizione terapeutica per la cura della psoriasi.
NO20010569D0 (no) Proteaseinhibitorer for anvendelse ved behandling av psoriasis
FI20012016A (fi) Eettereitä hajottavia bakteereita ja niiden käyttö
ATE226440T1 (de) Zusammensetzung zur behandlung von psoriasis
ITMI20001474A0 (it) Procedimoento per il dosaggio di tossine dsp del gruppo delle dinophysistossine e delle yessottossine
EE200300013A (et) Bispidiini uued ühendid ning nende kasutamine südame arütmia ravis